Rubella seroprevalence in Tunisian childbearing women two years after vaccination program introduction;Séroprévalence de la rubéole chez la femme en âge de procréer deux ans après l'introduction de la vaccination en Tunisie

Pathologie Biologie

Volumn 60, Issue 3, 2012, Pages 170-173

  Chaabouni, M ^a   Messadi, F ^b   Fki, L ^a   M, Zribi ^b   Hammami, A ^a   Karray, H ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

^b Laboratoire régional d'hygiène   (Tunisia)

Author keywords

Rubella; Seroepidemiology; Tunisia; Vaccination

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PARITY; PREGNANCY; PUERPERIUM; RUBELLA; SEROLOGY; SEROPREVALENCE; TUNISIA; VACCINATION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; FEMALE; HEALTH PLAN IMPLEMENTATION; HUMANS; MASS VACCINATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RUBELLA; RUBELLA VACCINE; RUBELLA VIRUS; SEROEPIDEMIOLOGIC STUDIES; TUNISIA; YOUNG ADULT;

EID: 84861670777     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2011.01.002     Document Type: Article

References (20)

1. Duszak R.S. Congenital rubella syndrome. Optometry 2009, 80:36-43.
2. De Santis M., et al. Rubella infection in pregnancy. Reprod Toxicol 2006, 21(4):390-398.
3. Lee J., Bowden D. Rubella virus replication and links to teratogenicity. Clin Microbiol Rev 2000, 13(4):571-587.
4. Dromigny J.A., et al. Seroprevalence of rubella in pregnant women at Antananarivo: study of 853 sera at the Pasteur Institute in Madagascar. Arch Inst Pasteur Madagascar 1996, 63:53-55.
5. Sasmaz T., et al. Rubella seroprevalence in women in the reproductive period, Mersin, Turkey. Vaccine 2007, 25:912-917.
6. Pehlivan E., et al. Rubella seroprevalence in an unvaccinated pregnant population in Malatya, Turkey. Public Health 2007, 121:462-468.
7. Gandhoke, et al. Seroprevalence and incidence of rubella in and around Delhi (1988-2002). Int J Med Microbiol 2005, 23(3):164-167.
8. Dromigny J.A., Nabeth P., Perrier Gros Claude J.D. Evaluation of the seroprevalence of rubella in the region of Dakar (Senegal). Trop Med Int Health 2003, 8(8):740-743.
9. Bartoloni A., et al. Seroprevalence of varicella zoster and rubella antibodies among rural populations of the Chaco region, south-eastern Bolivia. Trop Med Int Health 2002, 7(6):512-517.
10. Jarour N., et al. Seroprevalence of rubella among Jordanian women of childbearing age. Vaccine 2007, 25:3615-3618.
11. Sallam T.A., et al. Prevalence of antibodies to measles and rubella in Sana'a, Yemen. Vaccine 2006, 24:6304-6308.
12. Nabli B. Séro-épidémiologie de la rubéole en Tunisie. Bull World Health Organ 1970, 42:891-896.
13. Bchir A., et al. Séroprévalence de la rubéole dans la population scolarisée de Sousse. Med Mal Infect 1986, 7:475-477.
14. Bchir A., et al. évaluation de la réceptivité des femmes enceintes à la rubéole dans la région de Monastir. Med Mal Infect 1992, 22(11):919-922.
15. Haddad Boubaker S., et al. étude de l'infection par le virus de la rubéole chez l'enfant et l'adolescent en Tunisie. Pathol Biol 2004, 52:11-15.
16. Palihawadana P., Wickremasinghe A.R., Perera J. Seroprevalence of rubella antibodies among pregnant females in Sri Lanka, Southeast Asian. J Trop Med Public Health 2003, 34(2):398-404.
17. Lin D.B., Chen C.J. Current seroepidemiology of rubella infection among female residents in Taiwan. J Med Virol 1993, 41:174-178.
18. Rubella immunization programme, Singapore. Wkly Epidemiol Rec 1989, 64(19):144-145.
19. De Los Angelos Ribas M., et al. Role of virology in the surveillance of rubella virus Cuba 1988/2000. Vaccine 2004, 22:4287-4290.
20. Peltola H., et al. The elimination of indigenous measles, mumps, and rubella from finland by a 12-year, two-dose vaccination program. N Engl J Med 1994, 331:1397-1402.